Crestline Management’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-101,244
Closed -$9.59M 708
2024
Q3
$9.59M Sell
101,244
-78,541
-44% -$6.86M 0.5% 46
2024
Q2
$15M Buy
179,785
+23,078
+15% +$1.92M 1.17% 13
2024
Q1
$13.5M Sell
156,707
-63,094
-29% -$5.14M 1.19% 15
2023
Q4
$18.2M Buy
219,801
+16,018
+8% +$1.18M 1.55% 8
2023
Q3
$14.7M Hold
203,783
1.71% 5
2023
Q2
$15.4M Buy
203,783
+15,906
+8% +$1.07M 1.61% 8
2023
Q1
$11.9M Buy
187,877
+47,877
+34% +$2.81M 1.41% 9
2022
Q4
$7.61M Buy
140,000
+50,000
+56% +$2.97M 1.11% 16
2022
Q3
$5.15M Buy
+90,000
New +$4.99M 0.7% 35
2022
Q2
Sell
-100,000
Closed -$5.72M 223
2022
Q1
$5.72M Sell
100,000
-40,000
-29% -$2.06M 0.69% 28
2021
Q4
$7.38M Buy
140,000
+74,470
+114% +$3.98M 0.55% 33
2021
Q3
$3.29M Buy
65,530
+42,330
+182% +$2.19M 0.31% 72
2021
Q2
$1.36M Buy
+23,200
New +$1.43M 0.12% 94

Other funds holding ACA

Crestline Management's ACA Position: Q4 2024 in Review

Crestline Management sold out of Arcosa (ACA) in Q4 2024, closing a stake of 101,244 shares — an estimated $9.59M sold.

Crestline Management first reported a position in ACA in Q2 2021 and held it in 13 quarters. The position peaked at $18.2M in Q4 2023. 329 funds tracked by Wall St. Rank hold ACA as of Q4 2024.

  • Crestline Management reported no remaining Arcosa position as of Q4 2024 after selling out during the quarter.
  • Crestline Management sold 101,244 Arcosa shares in Q4 2024, an estimated $9.59M.
  • Crestline Management first reported a position in Arcosa in Q2 2021 and held it in 13 quarters.
  • Crestline Management's Arcosa position peaked at $18.2M in Q4 2023.
  • 329 funds tracked by Wall St. Rank held Arcosa as of Q4 2024.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.